510(k) Report

FDA applicant

Xvivo Perfusion AB

Englewood5 decisions2010–20261 recall

FDA records 5 decisions for Xvivo Perfusion AB (Englewood) from 2010 to 2026: 4 510(k) clearances and 1 original PMA approval. Most are in product codes KDN (System, Perfusion, Kidney) and PHO (Normothermic Preservation System For…). Its devices cite 5 predicates, 2 of them its own earlier devices. 1 recall is linked to its devices.

FDA’s records also spell it “Xvivo Perfusion, Inc.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, gastroenterology and urology panel, where it files most

How often FDA has decided Xvivo Perfusion AB’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2010: 12018: 12019: 12022: 12026 (partial year): 1
2010high 1 (2010) · low 0 (2011)2026

2026 so far, outlined.

Recalls per year

1in 2022

2022: 1
2010high 1 (2022) · low 0 (2010)2026

Class I Class II/III not classified

FIG. 1 — Xvivo Perfusion AB by year, 2010–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Xvivo Perfusion AB’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report